DUO
Investors

The company at the intersection of
legacy, health, and trust.

Category-defining, mission-locked, and built for generational scale.

Mission
Turn one life into endless impact — through consent-based research.
Market
$400B+ global research + $20B legacy giving. A convergent, underserved category.
Vision
A generational research infrastructure that families are proud to be part of.
Technology
Private compute, federated cohorts, and a governance-first data platform.
Business model
Partner subscriptions and research-access fees. Free for families forever.
Roadmap
2026 national scale · 2027 international · 2028 open cohorts for rare disease.
Roadmap

What we're building next

Q2 2026
National rollout
Scale to 1M families with 6 flagship partners.
Q4 2026
Global governance
International family council and ethics board.
Q2 2027
Rare disease cohorts
Open access programs for orphan diseases.
Q4 2027
Long-term outcomes
Multi-decade impact reporting across therapies.

Turn one life into endless impact.

Join the families and institutions building a healthier future — together.

Join DUO Talk to us